Raffaella Coccia
Rome, 00185, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
CURRENT DEVELOPMENTS IN DRUG ELUTING DEVICES: Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis.
Journal: Drug target insights
Published: January 18, 2017
Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.
Journal: Antioxidants & redox signaling
Published: September 15, 2016
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.
Journal: Free radical biology & medicine
Published: October 05, 2015
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Journal: Journal of neurochemistry
Published: October 20, 2014
Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.
Journal: Free radical biology & medicine
Published: January 20, 2014
Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.
Journal: Biochimica et biophysica acta
Published: January 17, 2014
Simvastatin attenuates the endothelial pro-thrombotic shift in saphenous vein grafts induced by Advanced glycation endproducts.
Journal: Thrombosis research
Published: September 25, 2013
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).
Journal: The American journal of cardiology
Published: February 01, 2013
Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
Journal: Biochimica et biophysica acta
Published: November 26, 2012
HO-1/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 11, 2012
Last Updated: 09/26/2026